Prof. Dr. Robert Grützmann

Lehrstuhl für Allgemein- und Viszeralchirurgie

N-glycosylation Regulates Intrinsic IFN-γ Resistance in Colorectal Cancer: Implications for Immunotherapy (2023) Krug J, Rodrian G, Petter K, Yang H, Khoziainova S, Guo W, Benard A, et al. Journal article Circulating Monocytes Serve as Novel Prognostic Biomarker in Pancreatic Ductal Adenocarcinoma Patients (2023) Hansen F, David P, Akram M, Knoedler S, Mittelstädt A, Merkel S, Podolska M, et al. Journal article Multicenter International Study of the Consensus Immunoscore for the Prediction of Relapse and Survival in Early-Stage Colon Cancer (2023) Mlecnik B, Lugli A, Bindea G, Marliot F, Bifulco C, Lee JKJ, Zlobec I, et al. Journal article NCR, an Inflammation and Nutrition Related Blood-Based Marker in Colon Cancer Patients: A New Promising Biomarker to Predict Outcome (2023) Langheinrich M, Siebenhüner AR, Baecker J, Miragall M, Wiesmüller F, Schellerer V, Merkel S, et al. Journal article Identification of Genes Associated with Liver Metastasis in Pancreatic Cancer Reveals PCSK6 as a Crucial Mediator (2023) He H, Zhang S, Yang H, Xu P, Kutschick I, Pfeffer S, Britzen-Laurent N, et al. Journal article CDK7 inhibition augments response to multidrug chemotherapy in pancreatic cancer (2022) Zeng S, Lan B, Ren X, Zhang S, Schreyer D, Eckstein M, Yang H, et al. Journal article Distinct mircobiomes in right- and left-sided colon cancer (2022) Langheinrich MC, Wirtz S, Kneis B, Weber K, Brunner M, Krautz C, Trebicka J, et al. Conference contribution Independent Validation and Assay Standardization of Improved Metabolic Biomarker Signature to Differentiate Pancreatic Ductal Adenocarcinoma From Chronic Pancreatitis (2022) Mahajan UM, Oehrle B, Sirtl S, Alnatsha A, Goni E, Regel I, Beyer G, et al. Journal article Clinical Performance of the Consensus Immunoscore in Colon Cancer in the Asian Population from the Multicenter International SITC Study (2022) Mlecnik B, Torigoe T, Bindea G, Popivanova B, Xu M, Fujita T, Hazama S, et al. Journal article An m5C methylation regulator-associated signature predicts prognosis and therapy response in pancreatic cancer (2022) Yun D, Yang Z, Zhang S, Yang H, Liu D, Grützmann R, Pilarsky C, Britzen-Laurent N Journal article